vedolizumab
Ligand Summary
a humanized monoclonal antibody that targets the 4beta7 integrin exclusively, and modulates inflammation in the gastrointestinal tract
ChEMBL: CHEMBL1743087
DrugCentral: 4982
LyCHI: vedolizumab
Target Activities
2 Activities
Items per page:
10
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ANTIBODY BINDING | |||||
IC50 | ANTIBODY BINDING | |||||